Videos
Andrew Callaghan and Hamilton Morris Weaponized My Abuser
Excerpt from "Hamilton's Pharma Cope, Part 4."
Videos
Excerpt from "Hamilton's Pharma Cope, Part 4."
Article
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Article
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Article
In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.
Article
In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.
Videos
Psymposia discusses more notable psychedelic figures who have turned up in the Epstein files — including Paul Krassner, Rupert and Merlin Sheldrake, Paul Daley, and more.
Videos
Psymposia discusses notable psychedelic figures who have turned up in the Epstein files — including major funders and investors Austin Hearst, Steve Jurvetson, and Kimbal Musk.
Videos
Psymposia discusses flaws in Andrew Callaghan's journalism, his response to sexual abuse allegations, and how it relates to our experience as the subjects of targeted reporting from Channel 5.
Videos
Psymposia senior writer Russell Hausfeld sits down with author Bitter Karella to discuss their debut novel "Moonflow," their micro-fiction and text adventure projects, psychedelic mushrooms, writing queer and trans horror stories, ritual magic and more.
Videos
Clip from Psymposia’s November 6, 2025 appearance on the Subliminal Jihad podcast, where the group discusses CEO of Tactogen, Dr. Matthew Baggott, getting caught using an AI bot on Reddit to spread misinformation about Psymposia.
Videos
Clip from Psymposia’s November 6, 2025 appearance on the Subliminal Jihad podcast, where the group discusses Psychedelic Science Funder's Collaborative donor Steve Jurvetson's vision for a future in which psychedelic therapy is performed by artificial intellignece.
Videos
Clip from Psymposia’s November 6, 2025 appearance on the Subliminal Jihad podcast, where the group discusses the attempts to scapegoat Psymposia for the failure of MAPS/Lykos Therapeutics' MDMA application and the actual reasons for rejection detailed within the FDA's Complete Response Letter.
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture. We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.